H1B Salary Data

Home › Employers › Pediatrix Medical Services Inc.

Pediatrix Medical Services Inc.: H-1B salaries and sponsorship

Pediatrix Medical Services Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $254,000.

Applications (LCAs)4
Certified4
Employer addressSunrise, FL
H-1B dependent employerNo
Median offered salary$254,000
Middle half of salaries$202,738–$306,250
10th–90th percentile$193,265–$317,500

Does Pediatrix Medical Services Inc. sponsor H-1B visas?

Pediatrix Medical Services Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 30, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Neonatologist3$300,000
Pediatric Urologist1$208,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$197,475
FY20241$300,000
FY20261$325,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Neonatologist$325,000–$355,000
Level IV
San Antonio, TXMar 30, 2026Apr 1, 2026Certified
Neonatologist$300,000
Level III
Webster, TXJun 12, 2024Aug 16, 2024Certified
Neonatologist$186,950–$205,000
Level II
Lubbock, TXApr 3, 2023Jul 1, 2023Certified
Pediatric Urologist$208,000–$425,000Edinburg, TXFeb 22, 2023Aug 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).